BeStock  
Stocks › Biotechnology › OCUL

Ocular Therapeutix OCUL

US equityMarket cap rank #2935Biotechnology
$7.25 +$0.29 (+4.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.25 -0.02%
Open$6.93
Prev close$6.96
Day range$6.79 – $7.27
Volume5.62M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$51.95M-18.5% YoY
Operating profit-$270.02M-57.2% YoY
Net profit-$265.94M-37.4% YoY
Diluted EPS-$1.42-16.4% YoY

Annual revenue

$17.4MFY20$43.5MFY21$51.5MFY22$58.4MFY23$63.7MFY24$52.0MFY25

Profitability & balance sheet

Gross margin87.3%
Operating margin-519.8%
Net margin-511.9%

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Operating Profit -$270.02M -$171.78M -$82.38M -$78.65M -$78.04M
Diluted EPS -$1.42 -$1.22 -$1.02 -$0.97 -$0.98
Research & Development $197.10M $127.64M $61.06M $53.46M $50.08M
-General & Admin Expense $112.15M $97.13M $69.66M $67.98M $31.88M
-Selling & Marketing Expense $6.15M $5.12M $4.83M $4.17M $35.19M
Selling and Admin Expenses $118.30M $102.24M $74.49M $72.15M $67.07M
Operating Expense $315.39M $229.88M $135.54M $125.61M $117.15M
Gross Profit $45.38M $58.10M $53.16M $46.95M $39.12M
Cost of Revenue $6.57M $5.63M $5.28M $4.54M $4.41M
Total Operating Revenue $51.95M $63.72M $58.44M $51.49M $43.52M
Total Revenue as Reported $51.95M $63.72M $58.44M $51.49M $43.52M
Net Non-Operating Interest Income (Expense) $6.52M $6.71M -$7.36M -$6.22M -$6.64M
Non-Operating Interest Income $18.36M $20.28M $3.98M $798,000.00 $33,000.00
Non-Operating Interest Expense $11.84M $13.58M $11.34M $7.02M $6.67M
Basic EPS -$1.42 -$1.22 -$1.01 -$0.92 -$0.09
Net Income to Common Stockholders -$265.94M -$193.51M -$80.74M -$71.04M -$6.55M
Net Income to Parent Company -$265.94M -$193.51M -$80.74M -$71.04M -$6.55M
Profit from Continuing Operations -$265.94M -$193.51M -$80.74M -$71.04M -$6.55M
Net Profit -$265.94M -$193.51M -$80.74M -$71.04M -$6.55M
Pretax Profit -$265.94M -$193.51M -$80.74M -$71.04M -$6.55M
Other Non-Operating Income (Expenses) $29,000.00 – -$1,000.00 -$1,000.00 $1,000.00
Special Income (Charges) $0.00 -$27.95M $14.19M $0.00 $0.00
Gain on Sale of Security -$2.47M -$480,000.00 -$5.19M $13.84M $78.12M
Other Income (Expense) -$2.44M -$28.43M $9.00M $13.84M $78.12M
-Less:Other Special Charges – $27.95M -$14.19M – –

Discussion

No comments yet — be the first to weigh in on OCUL.

Leave a comment

Scroll to Top